NEW YORK (Reuters Health) – imprägnierten Nähten mit
Triclosan nicht verringert die Häufigkeit von Infektionen des Standortes
chirurgische, nach einer Metaanalyse veröffentlicht in den Annalen der
Chirurgie.
die Autoren der Auffassung, dass “Weitere Studien sind erforderlich,
unabhängig und Qualität im Kontext Recht vor der
sehen den klinischen Einsatz der Routine” über diese Produkte.
angesichts der Bedeutung der mikrobiellen Besiedlung des die
resorbierbarer, sobald sie durch das Gewebe nach dem Vorkommen der gehen
Infektionen, chirurgische Website die Idee geben ihnen
antibakterielle Eigenschaften scheint logisch, sagt das Team von
,
Wai Keat Chang, von der University of Auckland in Otahuhu.
in USA, die Droge getränkt Nahtmaterial
Triclosan wurden im Jahr 2002 angenommen, aber noch nicht nachgewiesen
Ihre Security and its effectiveness. in fact, a study had
identified an increase in the risk of dehiscence (opening) of
wound.
for meta-analysis, the team found seven studies
randomized controlled about 836 patients. in that group, is
detected 30 443 closed wound infections with
impregnated with triclosan sutures and 35 infections in the 393
patients with incisions treated with traditional sutures.
in both groups were recorded, respectively, 17 and 10
healing of the wounds surgical complications that is
translates into a ratio of 1.07 risk.
Although triclosan-impregnated sutures showed
results promising in vitro and in vivo studies, the team
Chang believes that the results show the need of
count on high-quality research “before adopting
this” innovation in daily practice”.
and concludes:” in the absence of an obvious benefit, not is
can recommend the routine use of impregnated sutures in
triclosan. therefore, 43 percent is not justified of
increase estimated costs by the use of these sutures “.
this cost estimate does not include the environmental impact of the
triclosan, which is highly toxic to aquatic life. in
Sweden, impregnated with triclosan sutures are prohibited
in many hospitals by causes environmental. in 2010, Johnson
& Johnson, that produces these sutures, introduced unsuccessfully a
demand judicial to remove that ban.
Meanwhile, in the United States, the Food Administration
and medications and the environmental protection agency are
analyzing the safety of triclosan in antiseptic products
selling massive.
< p> Quelle: Annalen der Chirurgie, online 30. März 2012